IDEXX Laboratories stock falls 1.65 percent below USD 747 target
Published on 09/25/2026 at 12:47 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
IDEXX Laboratories (ISIN US45168D1046) stock was trading at USD 513.39 on Nasdaq on September 24, 2026 at 4:00 p.m. ET, down USD 8.63 or 1.65 percent from the prior close. The latest earnings comparison and the wide gap to analyst targets define the stock's current setup.
Stock tests yearly floor
The September 24 price stood USD 12.78 above the 52-week low of USD 500.61 and USD 256.59 below the 52-week high of USD 769.98. Trading volume was 328,284 shares on the same session, while IDEXX Laboratories carried a market capitalization of USD 40,497,743,370.
The price action gives the quarterly figures added weight. A share price near the yearly low contrasts with revenue growth and an earnings beat, leaving valuation expectations as the key point of tension.
Quarterly beat resets debate
MarketBeat reported on August 4, 2026 that IDEXX delivered quarterly EPS of USD 4.27 against a USD 3.94 consensus. Quarterly revenue reached USD 1.22 billion against USD 1.20 billion expected, and revenue increased 9.7 percent year over year.
The comparison is material because the earnings beat came with a higher full-year framework. Zacks wrote on September 9, 2026 that IDEXX raised fiscal 2026 revenue guidance to USD 4.70-4.75 billion and EPS guidance to USD 14.69-14.94.
Targets stay above price
Analyst expectations remain materially higher than the market quote. According to MarketBeat on September 10, 2026, the consensus rating was Moderate Buy and the average 12-month price target was USD 747.00, versus USD 513.39 in the Nasdaq session on September 24.
That USD 233.61 difference puts the average target well above the latest quoted price, but the 52-week range shows that the market has also repriced the stock sharply from its yearly peak. For investors, the next test is whether the raised fiscal framework can support a recovery in valuation.
Stock stays near yearly low
IDEXX Laboratories stock was trading at USD 513.39 on Nasdaq on September 24, 2026 at 4:00 p.m. ET. The company operates in healthcare, with a focus on medical diagnostics and research.
IDEXX Laboratories stock data
- Company: IDEXX Laboratories, Inc.
- ISIN: US45168D1046
- Ticker: IDXX
- Trading venue: Nasdaq
- Price (as of September 24, 2026, 4:00 p.m. ET): USD 513.39
- Market capitalization: USD 40,497,743,370 (as of September 24, 2026)
- 52-week range: USD 500.61-769.98 (as of September 24, 2026)
- Sector / Industry: Healthcare / Medical Diagnostics and Research
